MARSHALL WACE, LLP - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 118 filers reported holding IMMUNOVANT INC in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$226,501
-67.2%
5,900
-84.9%
0.00%
-100.0%
Q4 2022$691,416
+873.8%
38,953
+368.4%
0.00%
Q4 2021$71,000
-88.8%
8,316
-88.6%
0.00%
-100.0%
Q3 2021$633,000
+249.7%
72,822
+324.2%
0.00%
+200.0%
Q2 2021$181,000
-46.8%
17,167
-19.0%
0.00%
-50.0%
Q1 2021$340,000
+34.9%
21,194
+288.5%
0.00%
+100.0%
Q4 2020$252,000
-83.7%
5,455
-91.4%
0.00%
-90.9%
Q2 2020$1,546,000
+798.8%
63,511
+475.5%
0.01%
+450.0%
Q1 2020$172,00011,0360.00%
Other shareholders
IMMUNOVANT INC shareholders Q2 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,510,412$264,291,0006.36%
Ghost Tree Capital, LLC 525,000$18,475,0005.34%
Pinz Capital Management, LP 199,100$7,006,0002.56%
ACUTA CAPITAL PARTNERS, LLC 250,000$8,798,0002.39%
BVF INC/IL 1,198,427$42,173,0002.30%
Cormorant Asset Management, LP 1,637,951$57,639,0002.22%
Vivo Capital, LLC 1,042,460$36,684,0002.12%
Parkman Healthcare Partners LLC 150,151$5,284,0001.40%
MANGROVE PARTNERS IM, LLC 230,307$8,105,0001.02%
Ikarian Capital, LLC 321,887$11,328,0000.82%
View complete list of IMMUNOVANT INC shareholders